Ordinace pro TBC a respirační nemoci

The research at Ordinace pro TBC a respirační nemoci concentrates on respiratory tract diseases, with a primary focus on COPD, aiming to improve patient outcomes by testing new inhaled therapies and monitoring long‑term safety.

• Evaluation of add‑on inhaled anti‑inflammatory agents
• Reduction of moderate and severe exacerbations
• Long‑term safety monitoring in COPD patients

The site in Strakonice conducts these studies to expand treatment options for individuals living with chronic lung disease.

Investigations target severe eosinophilic asthma, evaluating novel oral compounds for sustained safety and better disease control in patients who have completed earlier Phase III studies.

• Long‑term safety assessment of oral agents
• Impact on eosinophil‑driven inflammation
• Extension studies following Phase III trials

Through these trials, the clinic seeks to offer new therapeutic avenues for people with difficult‑to‑treat asthma.